KIORA PHARMACEUTICALS INC
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $16.0M | $0 | — | $0 |
| Operating income | -$12.8M | $4.5M | -$12.6M | -$12.3M | -$14.2M |
| Operating expenses | $12.8M | $11.5M | $12.6M | $12.3M | $14.2M |
| Cash from operations | -$10.0M | $8.6M | -$9.6M | -$10.4M | -$10.7M |
| Capital expenditure | $110,789 | $6,256 | $0 | $0 | $63,865 |
| Free cash flow | -$10.1M | $8.6M | -$9.6M | -$10.4M | -$10.7M |
| Impairments | $0 | $104,167 | $0 | $0 | $4.0M |
| Total assets | $24.3M | $36.5M | $13.7M | $18.7M | $20.1M |
| Total liabilities | $8.1M | $10.7M | $7.6M | $7.3M | $5.6M |
Shares outstanding 4.4M · Free float 33.6%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.